Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis-expressed protein 264 (TEX264) is a single-pass transmembrane protein localized predominantly to the endoplasmic reticulum (ER), where it acts as a major receptor for selective reticulophagy (ER-phagy)—the process of selective degradation of ER fragments via autophagy[1][4][5][6]. It binds the autophagic protein LC3 and related ATG8 family members through a conserved C-terminal LC3-interacting region (LIR) motif, facilitating the sequestration and lysosomal degradation of ER during nutrient deprivation or cellular stress[1][2][4]. TEX264 is also implicated in DNA repair, participating in the resolution of DNA-protein cross-links by bridging VCP/p97 to damage sites and recruiting repair enzymes[2][4]. TEX264 is ubiquitously expressed, with high levels in testis, and localizes to various subcellular compartments including the ER membrane, autophagosome membrane, and replication forks[2][3]. As a functional reticulophagy receptor, TEX264 is central to ER homeostasis, cellular stress response, and genome maintenance[1][2][4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis-expressed protein 264 (TEX264).